investing-statsSEC Form 4 insider transactions

MLYS · Mineralys Therapeutics, Inc.

← all insiders

Pharmaceutical Preparations · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades14
Distinct insiders4
Bought$0
Sold$6.46M
Net flow$-6.46M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for MLYS
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-08-25Warren EricOfficer (Chief Commercial Officer)M sell10b5-17,437 7,437 Common Stock238,001filing
2026-08-25Warren EricOfficer (Chief Commercial Officer)S sell10b5-17,4370$25.98$193.2K38,400−16%−<0.01% (now 0.04%)filing
2026-08-25Warren EricOfficer (Chief Commercial Officer)M buy10b5-17,4370$13.24$98.5K45,837+19%+<0.01% (now 0.05%)filing
2026-08-12Ferguson James J. IIIOfficer (Chief Medical Officer)A buy135,000 135,000 Common Stock135,000filing
2026-08-12Ferguson James J. IIIOfficer (Chief Medical Officer)A buy102,4000102,400new+0.12% (now 0.12%)filing
2026-08-12Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-12,170 2,170 Common Stock13,024filing
2026-08-12Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-12,1700$27.09$58.8K51,384−4%−<0.01% (now 0.06%)filing
2026-08-12Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-12,1700$16.00$34.7K53,554+4%+<0.01% (now 0.06%)filing
2026-07-23Warren EricOfficer (Chief Commercial Officer)M sell10b5-17,438 7,438 Common Stock245,438filing
2026-07-23Warren EricOfficer (Chief Commercial Officer)S sell10b5-17,4380$26.87$199.9K38,400−16%−<0.01% (now 0.04%)filing
2026-07-23Warren EricOfficer (Chief Commercial Officer)M buy10b5-17,4380$13.24$98.5K45,838+19%+<0.01% (now 0.05%)filing
2026-07-20Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-1416 416 Common Stock3,334filing
2026-07-20Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-14160$26.53$11.0K51,384−0.8%−<0.01% (now 0.06%)filing
2026-07-20Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14160$15.44$6.4K51,800+0.8%+<0.01% (now 0.06%)filing
2026-07-15Congleton JonDirector, Officer (Chief Executive Officer)S sell10b5-110,7000$27.24$291.4K603,621−2%−0.01% (now 0.68%)filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-16,349 6,349 Common Stock0filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-14,167 4,167 Common Stock79,167filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-13,542 3,542 Common Stock109,792filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-16,3490$26.61$169.0K51,384−11%−<0.01% (now 0.06%)filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-114,0580$27.58$387.7K57,733−20%−0.02% (now 0.07%)filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-16,3490$1.08$6.9K71,791+10%+<0.01% (now 0.08%)filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14,1670$14.25$59.4K65,442+7%+<0.01% (now 0.07%)filing
2026-07-15Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-13,5420$10.20$36.1K61,275+6%+<0.01% (now 0.07%)filing
2026-07-10Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-12,171 2,171 Common Stock15,194filing
2026-07-10Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-12,1710$30.30$65.8K57,733−4%−<0.01% (now 0.07%)filing
2026-07-10Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-12,1710$16.00$34.7K59,904+4%+<0.01% (now 0.07%)filing
2026-06-30Congleton JonDirector, Officer (Chief Executive Officer)S sell10b5-117,0000$26.82$455.9K614,321−3%−0.02% (now 0.69%)filing
2026-06-30Congleton JonDirector, Officer (Chief Executive Officer)S sell10b5-158,0000$25.94$1.50M631,321−8%−0.07% (now 0.71%)filing
2026-06-30Warren EricOfficer (Chief Commercial Officer)M sell10b5-1104,124 104,124 Common Stock252,876filing
2026-06-30Warren EricOfficer (Chief Commercial Officer)S sell10b5-1104,1240$25.90$2.70M38,400−73%−0.12% (now 0.04%)filing
2026-06-30Warren EricOfficer (Chief Commercial Officer)M buy10b5-1104,1240$13.24$1.38M142,5243.7×+0.12% (now 0.16%)filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-1417 417 Common Stock3,750filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-14,167 4,167 Common Stock83,334filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-13,542 3,542 Common Stock113,334filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-14,5840$25.00$114.6K57,095−7%−<0.01% (now 0.06%)filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14170$15.44$6.4K61,679+0.7%+<0.01% (now 0.07%)filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14,1670$14.25$59.4K61,262+7%+<0.01% (now 0.07%)filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-19,8900$23.81$235.5K57,095−15%−0.01% (now 0.06%)filing
2026-06-17Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-13,5420$10.20$36.1K66,985+6%+<0.01% (now 0.08%)filing
2026-06-17Karydas DaphneDirectorM sell10b5-13,000 3,000 Common Stock38,000filing
2026-06-17Karydas DaphneDirectorS sell10b5-13,0000$25.00$75.0K6,200−33%−<0.01% (now <0.01%)filing
2026-06-17Karydas DaphneDirectorM buy10b5-13,0000$12.02$36.1K9,200+48%+<0.01% (now 0.01%)filing
2026-06-12Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-16,349 6,349 Common Stock6,349filing
2026-06-12Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-12,170 2,170 Common Stock17,365filing
2026-06-12Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-16,3490$23.93$151.9K63,443−9%−<0.01% (now 0.07%)filing
2026-06-12Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-16,3490$1.08$6.9K69,792+10%+<0.01% (now 0.08%)filing
2026-06-12Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-12,1700$25.00$54.3K63,443−3%−<0.01% (now 0.07%)filing
2026-06-12Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-12,1700$16.00$34.7K65,613+3%+<0.01% (now 0.07%)filing
2026-05-19Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-1417 417 Common Stock4,167filing
2026-05-19Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-14170$27.55$11.5K63,443−0.7%−<0.01% (now 0.07%)filing
2026-05-19Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14170$15.44$6.4K63,860+0.7%+<0.01% (now 0.07%)filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-14,166 4,166 Common Stock87,501filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-13,541 3,541 Common Stock116,876filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-16,348 6,348 Common Stock12,698filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-12,171 2,171 Common Stock19,535filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-114,0560$28.58$401.8K63,443−18%−0.02% (now 0.07%)filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14,1660$14.25$59.4K77,499+6%+<0.01% (now 0.09%)filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-13,5410$10.20$36.1K73,333+5%+<0.01% (now 0.08%)filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-16,3480$29.36$186.3K69,792−8%−<0.01% (now 0.08%)filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-16,3480$1.08$6.9K76,140+9%+<0.01% (now 0.09%)filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-12,1710$29.71$64.5K69,792−3%−<0.01% (now 0.08%)filing
2026-05-13Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-12,1710$16.00$34.7K71,963+3%+<0.01% (now 0.08%)filing
2026-04-21Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-1416 416 Common Stock4,584filing
2026-04-21Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-14160$31.33$13.0K69,792−0.6%−<0.01% (now 0.08%)filing
2026-04-21Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14160$15.44$6.4K70,208+0.6%+<0.01% (now 0.08%)filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-14,167 4,167 Common Stock91,667filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-13,542 3,542 Common Stock120,417filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-16,349 6,349 Common Stock19,046filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-16,3480$27.66$175.6K69,792−8%−<0.01% (now 0.08%)filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-114,0580$26.54$373.1K76,140−16%−0.02% (now 0.09%)filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-14,1670$14.25$59.4K90,198+5%+<0.01% (now 0.10%)filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-13,5420$10.20$36.1K86,031+4%+<0.01% (now 0.10%)filing
2026-04-15Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-16,3490$1.08$6.9K82,489+8%+<0.01% (now 0.09%)filing
2026-04-15Congleton JonDirector, Officer (Chief Executive Officer)S sell10b5-115,7300$26.83$422.0K689,321−2%−0.02% (now 0.78%)filing
2026-04-13Rodman David MalcomOfficer (Chief Medical Officer)M sell10b5-12,170 2,170 Common Stock21,706filing
2026-04-13Rodman David MalcomOfficer (Chief Medical Officer)S sell10b5-12,1700$27.38$59.4K76,140−3%−<0.01% (now 0.09%)filing
2026-04-13Rodman David MalcomOfficer (Chief Medical Officer)M buy10b5-12,1700$16.00$34.7K78,310+3%+<0.01% (now 0.09%)filing
2026-04-02Karydas DaphneDirectorM sell10b5-13,000 3,000 Common Stock41,000filing
2026-04-02Karydas DaphneDirectorS sell10b5-13,0000$25.00$75.0K6,200−33%−<0.01% (now <0.01%)filing
2026-04-02Karydas DaphneDirectorM buy10b5-13,0000$12.02$36.1K9,200+48%+<0.01% (now 0.01%)filing
2026-04-02Congleton JonDirector, Officer (Chief Executive Officer)S sell10b5-14530$27.05$12.3K705,051−<0.1%−<0.01% (now 0.80%)filing
2026-04-02Congleton JonDirector, Officer (Chief Executive Officer)S sell10b5-155,1830$26.54$1.46M705,504−7%−0.06% (now 0.80%)filing
2026-04-02Congleton JonDirector, Officer (Chief Executive Officer)S sell10b5-119,3640$25.50$493.8K760,687−2%−0.02% (now 0.86%)filing
2026-03-31RA CAPITAL MANAGEMENT, L.P. +4 moreDirectorP buy58,3000$24.16$1.41M5,825,521+1%+0.07% (now 6.6%)filing
2026-03-31RA CAPITAL MANAGEMENT, L.P. +4 moreDirectorP buy310,7000$23.67$7.35M5,767,221+6%+0.35% (now 6.5%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.